Skip to main content
. 2019 Sep 30;9(9):e032092. doi: 10.1136/bmjopen-2019-032092

Table 5.

Summary of outcome measures and results+

Wang et al Kaut et al Conte et al Tabbassum et al Fonteyn et al Im et al Leonardi et al de Oliveira et al 2018 de Oliveira et al 2015 Sawant and Gokhale 2015 Silva et al D’Abreu et al Assadi et al Lei et al Saute et alˆˆ Schulte et al Wessel et al Zesiewicz et al Shiga et al Liu et al Arpa et al Giordano et al Monte et al Sanz-Gallego et al Takei et al Takei et al Tsai et al Yang et al Berntsson et al Lo et al
Impairment ACRS NS NS
BARS NR
ICARS * NS * *
INAS NS
Leg pain questionnaire NR
NESSCA NS NS
SARA * * * * NS NS * NS *BG * NS * NS X
 Activity 6MWT *
8MWT NS *
ABC NS
Barthel Index NS NS
BBS NS * * * *
BEStest *BG NS
BORG NS
CCFS *BG
CGI* NS
CPET
DGI *
EDSS NS
EFAP *
Energy recovery/expenditure *
FIM/FIM-AM * NS
Kinematic recordings *
ˆLimit of stability test NR
MFES (Falls) NS
Muscle coactivation (EMG) *
Obstacle avoidance success *
OLS *
No of falls NS
Posturography NS *
SCAFI * *BG *
Spatiotemporal gait parameters NR * * *
Standing capacity *BG
25FWT *BG
10MWT NS *BG
TGI/tandem steps *BG SS
Total length travelled * *
Treadmill inclination (%) *
TUG NS
UHDRS-IV X
UPDRS NS
Walking capacity NS
 QOL# BAI NS
BDI NS *BG
EQ-5D NS X
Experience of training Q NR
Hamilton rating scale *
KATZ ADL NS
PGI global impression NS NS
PHQ-9 X
SDS NR NR
SF36 NS NS NR
WHOQOL-Bref X NS

Symbols: *, significant difference within groups or significant difference presingle and postsingle group; *BG, significant difference between groups; *ˆ, significant difference in CEPT duration. No significant change in VE peak or VO2 max; ˆ, activity and impairment measure; #, includes measures for depression, well-being and overall health; +, Note: only outcome measures clinically relevant to function and mobility shown (ie imaging results for brain glucose metabolism and brain metabolite ratios have been excluded); X, relationship between variables assessed only. Nil intervention. See table 3 for findings.

ABC, Short version of Activities-specific Balance Scale; ACRS, Ataxia Clinical Rating Scale; BAI, Beck Anxiety Inventory; BARS, Brief Ataxia Rating Scale; BBS, Berg Balance Scale; BDI, Beck Depression Inventory; BES test, Balance Evaluation System Test; BORG, Borg Rating of Perceived Exertion Scale; CCFS, Composite Cerebellar Functional Score; CGI, Clinical Global Impression; CPET, Cardiopulmonary Exercise Test; DGI, Dynamic Gait Index; EDSS, Extended Disability Status Scale of Kurtzke; EFAP, Emory Functional Ambulation Scale: Obstacle subtask; EQ-5D, EuroQol health related quality of life measure; FIM/FIM-AM, Functional Independence Measure + Functional Assessment Measure; 25FWT, 25-foot walk test; ICARS, International Cooperative Ataxia Rating Scale; INAS, Inventory of Non-Ataxia Symptoms; KATZ ADL, Katz index of independence in activities of daily living; MFES (Falls), Modified Falls Efficacy Scale; 6MWT, 6-min walk test; 8MWT, 8 metre walk test; 10MWT, Timed 10 min walk test; NESSCA, Neurological Examination Score for SCA; OLS, one leg standing; PGI, Patient Global Impression; PHQ-9, Patient health questionnaire; Q, questionnaire; QOL, quality of life; SARA, Scale for Assessment and Rating of Ataxia; SCAFI, SCA Functional Index: Incudes 9HPT, 8MWT, PATA syllables within 10s test (PATA); SDS, Self-rating Depression Scale; SF-36, Short form 36 health survey; TUG, Timed Up and Go Test; UHDRS-IV, Unified Huntington’s Disease Rating Scale; UPDRS, Unified Parkinson’s Disease Rating Scale; WHOQOL-BREF, World Health Organisation Quality of Life Questionnaire.